HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: A meta-analysis (1988-2007)

Annals of Oncology

Volumn 19, Issue 10, 2008, Pages 1681-1690

  Termine, N ^a   Panzarella, V ^a   Falaschini, S ^a,b   Russo, A ^a   Matranga, D ^a   Lo Muzio, L ^b   Campisi, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Biopsy; Head and neck squamous cell carcinoma (HNSCC); Human papillomavirus (HPV); Meta analysis; Oral squamous cell carcinoma (OSCC)

Indexed keywords

VIRUS DNA;

CELL HETEROGENEITY; CLINICAL TRIAL; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; IN SITU HYBRIDIZATION; META ANALYSIS; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TUMOR BIOPSY; VIRUS DETECTION; WART VIRUS;

EID: 53049103211     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn372     Document Type: Review

References (105)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94.
2. Funk GF, Kamell LH, Robinson RA et al. Presentation, treatment, and outcome of oral cavity cancer: A National Cancer Data Base, report. Head Neck 2002; 24: 165-180.
3. Sydanen S. Human papillomavirus infections and oral tumors. Med Microbiol Immunol 2003; 192: 123-128.
4. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 2000; 36: 256-263.
5. Califano J, van der Riet P, Viestra W et al. Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 1996; 56: 2488-2492.
6. Pande P, Soni S, Kaur J et al. Prognostic factors in betel and tobacco related oral cancer. Oral Onool 2002; 38: 491-499.
7. Franceschi S, Levi F, La Vecchia C. Comparison of the effect of smoking and alcohol drinking between oral and pharyngeal cancer. Int J Cancer 1999; 83: 1-4.
8. Mashberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993; 72: 1369-1375.
9. La Vecchia C, Tavani A, Franceschi S et al. Epidemiology and prevention of oral cancer. Oral Oncol 1997; 33: 302-312.
10. Johnson NW, Wamakulasurlya KA. Epidemiology and aetiology of oral cancer in the United Kingdom. Community Dent Health 1993; 10 (Suppl 1): 13-29.
11. Zheng TZ, Boyle P, Hu HF et al. Dentition, oral hygiene, and risk of oral cancer: A case-control study in Beijing, People's Republic of China. Cancer Causes Control 1990; 1: 235-241.
12. Girja KP, Sundharam BS, Krishnan PA, Devi CS. Biochemical changes of saliva in tobacco chewers tobacco smokers, alcohol consumers, leukoplakia and oral cancer patents. Indian J Dent Res 2002; 13: 102-107.
13. Zavras AJ, Douglass CW, Joshipura K et al. Smoking and alcohol in the etiology of oral cancer: Gender-specific risk profiles in the south of Greece. Oral Oncol 2001; 37: 28-35.
14. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
15. Syrjanen K, Syrjanen S, Lamberg M et al. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) Involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983; 12: 418-424.
16. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996; 1288: F55-F78.
17. D'Costa J, Saranath D, Dedhia P et al. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998; 34: 413-420.
18. zur Hausen H. Papillomavirus and cancer: From basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350.
19. Erdmann J. Recent studies attempt to clarify relationship between oral cancer and human papillomavirus. J Nalt Cancer Inst 2003; 95: 638-639.
20. Nair S, Pillai M. Human papillomavirus and disease mechardsms: Relevance to oral and cervical cancers. Oral Dis 2005; 11: 350-359.
21. van Regenmortel MHV FC, Bishop DHL, Carstens E et al. (eds): Virus Taxonomy. Seventh Report of the International Committee on Taxonomy of Viruses. New York: Academic Press 2000.
22. de Villiers EM, Fauquet C, Broker TR et al. The human papillomavirus database. J Biomed Sci 2004; 2: 90-104.
23. Bernard H-u. The clinical Importance of the nomenclature, evolution and taxonomy of the human papillomaviruses. J Clin Virol 2005; 32S: S1-S5.
24. Bosh FX, Lorincz A, Munoz N et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
25. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
26. Thompson IO, van der Bijl P, van Wyk CW, van Eyk AD. A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium. Arch Oral Biol 2001; 46: 1091-1098.
27. Ragin CCR, Modugno F, Gollin SM. The epidemiology and risk factors of Head and Neck Cancer: A focus on Human Papillomavirus. J Dent Res 2007;86:104-114.
28. Al-Bakkal G, Ficarra G, McNeill K et al. Human papilloma virus type 16 E6 gene expression in oral exophylic epithelial lesions as detected by in situ rtPCR. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 197-208.
29. Boy S, Van Rensburg E.J, Engelbrecht S et al. HPV detection in primary intraoral squamous cell carcinomas - commensal, aetiological agent or contamination? J Oral Pathol Med 2006; 35: 86-90.
30. Terai MTM. Human papillomavirus in oral cavity. Oral Med Pathol 2001; 6:1-12.
31. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475.
32. Hebner CM, Laimins LA. Human papillomaviruses: Basic mechanisms of pathogenesis and onoogenicity. Rev Med Virol 2005.
33. Scheurer ME, Tortolero-Lunay G, Adler-Storthzz K. Human papillomavirus infection: Biology, epidemiology, and prevention. Int J Gynecol Cancer 2005; 15: 727-746.
34. Watts SL, Brewer EE, Fry TL. Human papillomavirus DNA types in squamous cell carcinomas of the head and neck. Oral Surg Oral Med Oral Pathol 1991; 71: 701-707.
35. Kumar RV, Kadkol SS, Daniel R et al. Human papillomavirus, p53 and cyclin D1 expression in oropharyngeal carcinoma. Int J Oral Maxillofac Surg 2003; 32: 539-543.
36. Deeks JJ, Altman DG, Bradburn W. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In Egger M, Davey Smith G, Altman DG (ads): Systematic Reviews in Health Care. Meta-analysis in Context, 2nd edn. London: BW Books 2001.
37. Fleiss JL. Analysis of data from multiclinic tFials. Control Clin Trials 1994; 7: 267-275.
38. DerSimonnian R, Laird NM. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
39. Greenland S. Invited commentary: A critical look at some popular meta-analytic methods. Am J Epidemiol 1994; 140: 290-296.
40. Fouret P, Martin F, Rahault A, Saint-Guily JL. Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn Mol Pathol 1995; 4: 122-127.
41. Fouret P, Monceaux G, Temam S et al. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 1997; 123: 513-516.
42. Portugal LG, Goldenberg JD, Wenig BL et al. Human papillomavirus expression and p53 gone mutations in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1997; 123: 1230-1234.
43. Pintos J, Franco EL, Black MJ et al. Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract Cancer 1999; 85: 1903-1909.
44. Lindel K, Beer KT, Laissue J et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx: A radiosensitive subgroup of head and neck carcinoma. Cancer 2001; 92: 805-813.
45. Mork J, Lie AK, Glattre E et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck N Engl J Med 2001; 344: 1125-1131.
46. Ha PK, Pai SI, Westra WH et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 2002; 8: 1203-1209.
47. Dahlstrom KR, Adler-Storthz K, Etzel CJ et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: A matched pair analysis. Clin Cancer Res 2003; 9: 2620-2626.
48. Paradiso A, Ranieri G, Stea B et al. Altered p161NK4a and Fhit expression in carcinogenesis and progression of human oral cancer. Int J Oncol 2004; 24: 249-255.
49. Yang YY, Koh LW, Tsai JH et al. Involvement of viral and chemical factors with oral cancer In Taiwan. Jpn J Clin Oncol 2004; 34: 176-183.
50. Tachezy R, Klozar J, Salakova M et al. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Dis 2005; 11: 181-185.
51. Hammarstedt L, Lindquist D, Dahlstrand H et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006; 119: 2620-2623.
52. Syrjanen SM, Syrjanen KM, Happonen RP. Human papillomavirus (HPV) DNA sequences in oral precanoerous lesions and squamous cell carcinoma demonstrated by in situ hybridization. J Oral Patholl 1988; 17: 273-278.
53. Chang F, Syrjanen S, Nuutinen J et al. Detection of human papillomavirus (HPV) DNA in oral squamous cell carcinomas by in situ hybridization and polymerase chain reaction. Arch Dermatol Res 1990; 282: 493-497.
54. Greer RO Jr., Eversole LR, Crosby LK. Detection of human papillomavirus-genomic DNA in oral epithelial dysplasias, oral smokeless tobacoo-associated leukoplakias, and epithelial malignancies. J Oral Maxillofac Surg 1990; 48: 1201-1205.
55. Young SK, Min KW. In situ DNA hybridization analysis of oral papillomas, leukoplakias, and carcinomas for human papillomavirus. Oral Surg Oral Med Oral Pathol 1991; 71: 726-729.
56. Zeuss MS, Miller CS, White DK. In situ hybridization analysis of human papillomavirus DNA in oral mucosal lesions. Oral Surg Oral Med Oral Pathol 1991; 71: 714-720.
57. Holladay EB, Gerald WL. Viral gene detection in oral neoplasms using the polymeras;e chain reaction. Am J Clin Pathol 1993; 100: 36-40.
58. Brandwein M, Zeitlin J, Nuovo GJ et al. HPV detecton using "hot start" polymerase chain reaction in patients with oral cancer: A clinicopathological study of 64 patients. Mod Pathol 1994; 7: 720-727.
59. Gonzalez-Moles MA, Ruiz-Avila I, Gonzalez-Moles S et al. Detection of HPV DNA by in situ hybridization in benign, premalignant and malignant lesions of the oral mucosa. Bull Group Int Rech Sci Stomatol Odontol 1994; 37: 79-85.
60. Shindoh M, Chiba I, Yasuda M et al. Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression. Cancer 1995; 76: 1513-1521.
61. Van Rensburg EJ, van Heerden WF, Venter EH, Raubenhelmer EJ. Detection of human papillomavirus DNA with in situ hybridisation in oral squamous carcinoma in a rural black population. S Afr Mad J 1995; 85: 894-896.
62. Cruz IB, Snijders PJ, Steenbergen RD et al. Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J Cancer B Oral Onool 1996; 32B: 55-62.
63. Mao EJ, Schwartz SM, Daling JR et al. Human papilloma viruses and p53 mutations in normal pre-malignant and malignant oral epithelia. Int J Cancer 1996; 69: 152-158.
64. Van Rensburg EJ, Engelbrecht S, Van Heerden WF et al. Human papillomavirus DNA in oral squamous cell carcinomas from an African population sample. Anticancer Res 1996; 16: 969-973.
65. Wen S, Tsuji T, Li X et al. Detection and analysis of human papillomavirus 16 and 18 homologous DNA sequences in oral lesions. Anticancer Res 1997; 17: 307-311.
66. Ibrahim SO, Bertelsen B, Kalvenes MB et al. Expression of keratin 13, 14 and 19 in oral squamous cell carcinomas from Sudanese snuff dippers: lack of association with human papillomavirus infection. Apmis 1998; 106: 959-969.
67. Koh JY, Cho NP, Kong G et al. p53 mutations and human papillomavirus DNA in oral squamous cell carcinoma: Correlation with apoptosis. Br J Cancer 1998; 78: 354-359.
68. Premoli-De-Percoco G, Ramirez JL, Galindo I. Correlation between HPV types associated with oral squamous cell carcinoma and cervicovaginal cytology: An in situ hybridization study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 77-81.
69. Schwartz SM, Daling JR, Doody DR et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998; 90: 1626-1636.
70. Aggelopoulou EP, Skarlos D, Papadimitriou C et al. Human papilloma virus DNA detection in oral lesions in the Greek population. Anticancer Res 1999; 19: 1391-1395.
71. Pillai MR, Phanidhara A, Kesari AL et al. Cellular manifestations of human papillomavirus infection in the oral mucosa. J Surg Oncol 1999; 71: 10-15.
72. Badaracco G, Venuti A, Morello R et al. Human papillomavirus in head and neck carcinomas: Prevalence, physical statusand relationship with clinical/pathological parameters. Anticancer Res 2000; 20: 1301-1305.
73. Bouda M, Gorgoulis VG, Kastrinakis NG et al. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000; 13: 644-653.
74. Cao J, Zhang ZY, Patima et al. Human papillomavirus infection and p53 alteration in oral squamous cell carcinoma. Chin J Dent Res 2000; 3: 44-49.
75. Patima Cao J, Chen, WT, Zhang ZY. Detection of high risk human papillomavirus DNA in oral squamous cell carcinoma. Shanghai Kou Qiang Yi Xue 2000; 9: 212-215.
76. Sand L, Jalouli J, Larsson PA, Hirsch JM. Human papilloma viruses in oral lesions. Anticancer Res 2000; 20: 1183-1188.
77. Tsuhako K, Nakazato I, Miyagi J et al. Comparative study of oral squamous cell carcinoma in Okinawa, Southern Japan and Sapporo in Hokkaido, Northern Japan; with special reference to human papillomavirus and Epstein-Barr virus infection. J Oral Pathol Med 2000; 29: 70-79.
78. Premoli-De-Percoco G, Ramirez JL. High risk human papillomavirus in oral squamous carcinoma: Evidence of risk factors in a Venezuelan rural population. Preliminary report. J Oral Pathol Med 2001; 30: 355-361.
79. Schwartz SR, Yueh B, McDougall JK et al. Human papillomavirus infection and survival in oral squamous cell cancer: A population-based study. Otolaryngol Head Neck Surg 2001; 125: 1-9.
80. Chen PC, Kuo C, Pan CC, Chou MY. Risk of oral cancer associated with human papillomavirus infection, betel quid chewing, and cigarette smoking in Taiwan - an integrated molecular and epidemiological study of 58 cases. J Oral Pathol Med 2002; 31: 317-322.
81. Kojima A, Maeda H, Sugita Y et al. Human papillomavirus type 38 infection in oral squamous cell carcinomas. Oral Oncol 2002; 38: 591-596.
82. Nagpal JK, Patnaik S, Das BR. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 2002; 97: 649-653.
83. Chang JY, Lin MC, Chiang CP. High-risk human papillomaviruses may have an important role in non-oral habits-associated oral squamous cell carcinomas in Taiwan. Am J Clin Pathol 2003; 120: 909-916.
84. Fregonesi PA, Teresa DB, Duarte RA et al. p16(INK4A) immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem 2003; 51: 1291-1297.
85. Kansky AA, Poljak M, Seme K et al. Human papillomavirus DNA in oral squamous cell carcinomas and normal oral mucosa. Acta Virol 2003; 47: 11-16.
86. Ritchie JM, Smith EM, Summersgill KF et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003; 104: 336-344.
87. Sugiyama M, Bhawal UK, Dohmen T et al. Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 594-600.
88. Correnti M, Rivera H, Cavazza ME. Detection of human papillomaviruses of high oncogenic potential in oral squamous cell carcinoma in a Venezuelan population. Oral Dis 2004; 10: 163-166.
89. Dahlgren L, Dahlstrand HM, Lindquist D et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 2004; 112: 1015-1019.
90. Smith EM, Ritchie JM, Summersgill KF et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004; 108: 766-772.
91. Zhang ZY, Sdek P, Cao J, Chen WT. Human papillomavirus type 16 and 18 DNA in oral squamous cell carcinoma and normal mucosa. Int J Oral Maxillofac Surg 2004; 33: 71-74.
92. El-Mofty SK, Patil S. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: Characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 339-345.
93. Nemes JA, Deli L, Nemes Z, Marton IJ. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 344-352.
94. Rivero ER, Nunes FD. HPV in oral squamous cell carcinomas of a Brazilian population: Amplification by PCR. Pesqui Odontol Bras 2006; 20: 21-24.
95. Koyama K, Uobe K, Tanaka A. Highly sensitive detection of HPV-DNA in paraffin sections of human oral carcinomas. J Oral Pathol Med 2007; 36: 18-24.
96. Sugiyama M, Bhawal UK, Kawamura M et al. Human papillomavirus-16 in oral squamous cell carcinoma: Clinical correlates and 5-year survival. Br J Oral Maxillofac Surg 2007; 45: 116-122.
97. Longworth MS, Laimins LA. Pathogenesis of human papillomavirus in differentiating epithelia. Microbiol Mol Biol Rev 2004; 68: 362-372.
98. Miller CS, White DK. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: A retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 57-68.
99. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: A meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91: 622-635.
100. Herrero R, Castellsague X, Pawlita M et al. Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95: 1772-1783.
101. Greene FL, Page DL, Fleming ID et al. American Joint Committee on Cancer. AJCC Cancer Staging Manual. New York: Springer-Verlag 2002.
102. Steenbergen RD, Hermesen MA, Walboomers JM et al. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 1995; 55: 5465-5471.
103. Uobe K, Masuno K, Fang YR et al. Detection of HPV in Japanese and Chinese oral carcinomas by in situ PCR. Oral Oncol 2001; 37: 146-152.
104. Balaram P, Nalinakumari KR, Abraham E et al. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int J Cancer 1995; 61: 450-454.
105. Van Rensburg EJ ES, Van Heerden WF, Raubennheimer EJ, Schoub BD. Human papillomavirus DNA in oral squamous cell carcinomas from an African population sample. Anticancer Res 1996; 16: 969-973.